The Future of Peptides: What Patients and Providers Should Know
By: Zoey Chotiner
What are peptides, and how do they work?
Peptides have become increasingly popular in medicine, wellness, and weight loss. Peptides are short chains of amino acids, which are the building blocks of proteins, and they can have a wide range of effects on the body. They can be thought of as smaller and simpler versions of proteins that can help regulate hormone activity, immune defenses, tissue repair, and growth. Peptides are used in some FDA-approved medications to treat disorders such as diabetes and obesity. For instance, injectable insulin and GLP-1 medications are examples of peptide-based drugs. Many people also use peptide injections and supplements to enhance their health and fitness goals.
Federal Law and Peptides
At the federal level, the Food and Drug Administration (FDA) regulates peptide drugs. They are regulated under the same general framework as other drugs. Usually, a drug must receive FDA approval after studies of its safety and effectiveness before it can be marketed for treatment. However, there is an exception for certain compounded medications. A compounded medication is essentially a custom drug created by a pharmacist or physician who combines or alters ingredients to fit the specific needs of a patient. A drug may be compounded for a patient who cannot be appropriately treated with an FDA-approved medication. However, compounded drugs are not reviewed or approved by the FDA for safety and effectiveness in the same way as FDA-approved drugs.
Under Section 503A of the Federal Food, Drug, and Cosmetic Act, pharmacists and physicians are not allowed to choose any peptide they want and compound it for patients. They may only compound drug products using bulk drug substances that comply with an applicable United States Pharmacopeia (USP) or National Formulary (NF) monograph, are components of FDA-approved drug products if an applicable USP or NF monograph does not exist, or appear on the FDA’s list of bulk drug substances that may be used in compounding. Bulk drug substances must also be accompanied by a valid certificate of analysis and manufactured by an establishment registered with the FDA.
Many peptides are marketed or labeled as “for research use only” or “not for human consumption.” This generally means they are being sold for laboratory or experimental purposes rather than as approved medical treatments. However, some suppliers market research peptides directly to consumers in ways that suggest human use. This can create legal risks, especially when the products are promoted as providing health, wellness, or other medical benefits.
Florida Law and Peptides
In Florida, peptide use is regulated by a combination of federal FDA rules and state healthcare regulations. The Florida Board of Medicine oversees physicians who prescribe or administer peptide treatments, while the Florida Board of Pharmacy regulates pharmacies and compounding practices. The Florida Department of Health oversees these professional boards and helps enforce state healthcare laws.
Florida does not currently have a separate law that specifically regulates all peptides as one category. Instead, peptides are generally managed by existing Florida drug, pharmacy, prescribing, and professional practice rules. This means the legal status of a peptide may depend on what the substance is, whether it requires a prescription, whether it is FDA-approved, how it is compounded, and how it is being sold or marketed.
Recent FDA Developments
Recently, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) voted in favor of adding six peptides—BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax—to the list of bulk drug substances that may be used under Section 503A. This is a major development for the compounding industry. These peptides have been proposed for uses involving ulcerative colitis, insomnia, wound healing, migraines, and other conditions. However, this does not mean the peptides are FDA-approved. The process can take time, and the FDA still has to decide whether to formally allow these peptides to be used in compounding. If the FDA does move forward, patients may have a clearer way to access them through licensed physicians and compounding pharmacies instead of relying on unregulated online vendors.
Some view this as a victory for patients and personalized medicine, while others are concerned that there is not enough data on the peptides’ safety and effectiveness to support wider access. Just because a peptide is being considered for addition to the compounding list does not mean it has full FDA approval. The FDA has raised concerns about the available information regarding the safety, effectiveness, and quality of some of these substances. Now, the FDA must decide what to do with the advisory committee’s recommendations while considering those concerns. The committee’s recommendations can carry significant weight in the FDA’s decision-making process, but they are advisory rather than binding. Ultimately, it is up to the FDA whether it chooses to follow recommendations.
Future of Peptides
In the future, peptides could become easier to access through licensed physicians and compounding pharmacies if the FDA allows more of them to be legally compounded. This could make patients less likely to rely on unregulated websites or “research use only” products. At the same time, newer drugs show how much potential peptide-based treatments may have in certain areas of health.
However, greater access will likely come with more rules and regulations. The FDA will most likely continue to focus on safety, product quality, clinical evidence, and how these drugs are marketed. Ultimately, peptides may become a much larger part of mainstream medicine, but their future will depend on stronger research, clearer legal pathways, and tighter regulation.
***************************************************
It should be noted that I am not your lawyer (unless you have presently retained my services through a retainer agreement). This post is not intended as legal advice; it is purely educational and informational, and no attorney-client relationship shall result after reading it. Please consult your own attorney for legal advice. If you do not have one and would like to retain my legal services, please get in touch with me using the contact information listed above.
All information and references to laws, rules, regulations, and advisory opinions were accurate as of this time, but laws are constantly evolving. Please get in touch with me to ensure that the law governing your business is up to date. Thank you.